[ad_1]
According to a new report, researchers in the UK and the US have low levels of biosecurity and biosecurity in three quarters of the 59 level 4 (BSL-4) biosecurity facilities around the world that deal with dangerous pathogens. I found out there is.
The measurements are based on the Global Health Security Index, which examines whether countries have laws, regulations, regulators and policies and is trained in biosecurity and biosecurity.
The 59 facilities include those in operation, under construction or planned, in 23 countries, including the UK, US, China and India.
The team also notes that three-quarters of these labs are located in urban areas, more than half are government-run, and the rest are located in universities.
Scroll down to see the video
These facilities include those in operation, under construction or planned and span 23 countries, including the United Kingdom, United States, China and India. The team also notes that three-quarters of these labs are located in urban areas, more than half are government-run, and the rest are located in universities.
Gregory Koblenz, associate professor of biodefence at George Mason University, and Philipparenzos of King’s College London conducted a study to determine how many would pass the safety protocol.
DailyMail.com has contacted the researchers for more information but has not yet received a response.
The team suggests that the World Health Organization should be responsible for monitoring such facilities to ensure that all laboratories are comparable to current protocols.
“Our research also revealed that there is room for significant improvements in policies to ensure that these laboratories operate in a safe, reliable and responsible manner,” said Koblenz and Renzos. I’m writing in the Guardian newspaper.
“Most countries with BSL-4 laboratories are of the kind of function acquisition study that is a central feature of the COVID-19 origin debate, as it can cause potential losses from Wuhan. No surveillance. Institute of Virology, ”they added.
The Wuhan Institute of Vessel Virus is one of 59 laboratories dealing with dangerous pathogens.
Biosafety and Biosafety Scores are based on the Nuclear Threat Initiative’s Global Health Security Index. This index measures “whether each country has the legal and institutional elements necessary for a country’s biosecurity and biosecurity monitoring system”.
Europe has the largest number of 25 BSL-4 laboratories, but North America and Asia are more or less the same, with 14 and 13 facilities respectively.
However, only 40% of countries with BSL-4 laboratories are members of an international group of biosecurity and biosecurity experts, and regulators share best practices for handling hazardous pathogens.
Members include Australia, Canada, France, Germany, Japan, Singapore, Switzerland, the United Kingdom and the United States.
Biosafety and Biosafety Scores are based on the Nuclear Threat Initiative’s Global Health Security Index. Measures “whether a country has the necessary legal and institutional elements for a country’s biosecurity and biosecurity monitoring system”.
The new report has raised concerns among experts who fear that deregulation in some places could lead to another pandemic.
“The more facilities we have and the more individuals have access to these dangerous drugs, the greater the risk,” Richard Ebright, a professor of chemical biology at Rutgers University, told the Financial Times. ‘
Accidents and leaks are already very common, especially in areas with weak biosecurity standards.
We need to strengthen biosecurity and biosecurity rules around the world, Ebright added.
75% of the world’s 59 laboratories dealing with deadly pathogens receive low biosecurity and safety scores
Link to source 75% of the world’s 59 laboratories dealing with deadly pathogens receive low biosecurity and safety scores
[ad_2]
picture credit